Next-generation sequencing for the diagnosis of hepatitis B: current status and future prospects

Expert Rev Mol Diagn. 2021 Apr;21(4):381-396. doi: 10.1080/14737159.2021.1913055. Epub 2021 Apr 21.

Abstract

Introduction: Hepatitis B virus (HBV) causes a complex and persistent infection with a major impact on patients health. Viral-genome sequencing can provide valuable information for characterizing virus genotype, infection dynamics and drug and vaccine resistance.

Areas covered: This article reviews the current literature to describe the next-generation sequencing progress that facilitated a more comprehensive study of HBV quasispecies in diagnosis and clinical monitoring.

Expert opinion: HBV variability plays a key role in liver disease progression and treatment efficacy. Second-generation sequencing improved the sensitivity for detecting and quantifying mutations, mixed genotypes and viral recombination. Third-generation sequencing enables the analysis of the entire HBV genome, although the high error rate limits its use in clinical practice.

Keywords: Diagnosis; hepatitis b virus; minor variants; next-generation sequencing; prognostic factors; quasispecies.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • DNA, Viral / genetics
  • Genotype
  • Hepatitis B virus / genetics
  • Hepatitis B* / diagnosis
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Quasispecies

Substances

  • DNA, Viral